FIA
ALDX icon

FNY Investment Advisers’s Aldeyra Therapeutics ALDX Stock Holding History

FNY Investment Advisers’s Portfolio ALDX Stock Details ALDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-100
Closed – – 759
2020
Q3 		$0 Hold
100
– – ﹤0.01% 472
2020
Q2 		$0 Hold
100
– – ﹤0.01% 408
2020
Q1 		$0 Hold
100
– – ﹤0.01% 434
2019
Q4 		$0 Hold
100
– – ﹤0.01% 800
2019
Q3 		$0 Buy
+100
New +$538 ﹤0.01% 866
2018
Q4 		– Sell
-30,405
Closed -$419K – 662
2018
Q3 		$419K Buy
30,405
+20,405
+204% +$166K 0.1% 124
2018
Q2 		$79K Buy
+10,000
New +$79.8K 0.03% 248

Other funds holding ALDX

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return

FNY Investment Advisers's ALDX Position: Q4 2020 in Review

FNY Investment Advisers sold out of Aldeyra Therapeutics (ALDX) in Q4 2020, closing a stake of 100 shares.

FNY Investment Advisers first reported a position in ALDX in Q2 2018 and held it in 7 quarters. The position peaked at $419K in Q3 2018. 98 funds tracked by Wall St. Rank hold ALDX as of Q4 2020.

  • FNY Investment Advisers reported no remaining Aldeyra Therapeutics position as of Q4 2020 after selling out during the quarter.
  • FNY Investment Advisers sold 100 Aldeyra Therapeutics shares in Q4 2020.
  • FNY Investment Advisers first reported a position in Aldeyra Therapeutics in Q2 2018 and held it in 7 quarters.
  • FNY Investment Advisers's Aldeyra Therapeutics position peaked at $419K in Q3 2018.
  • 98 funds tracked by Wall St. Rank held Aldeyra Therapeutics as of Q4 2020.

Based on FNY Investment Advisers's 13F filing for Q4 2020, filed 19 Jan 2021.